학술논문
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Holmes, Frankie A.; Moy, Beverly; Delaloge, Suzette; Chia, Stephen K.L.; Ejlertsen, Bent; Mansi, Janine; Iwata, Hiroji; Gnant, Michael; Buyse, Marc; Barrios, Carlos H.; Silovski, Tajana; Šeparović, Robert; Bashford, Anna; Zotano, Angel Guerrero; Denduluri, Neelima; Patt, Debra; Gokmen, Erhan; Gore, Ira; Smith, John W., II; Loibl, Sibylle; Masuda, Norikazu; Tomašević, Zorica; Petráková, Katarina; DiPrimeo, Daniel; Wong, Alvin; Martin, Miguel; Chan, Arlene
Source
In European Journal of Cancer May 2023 184:48-59
Subject
Language
ISSN
0959-8049